Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Thomas Nerreter
Observed names:
Nerreter, Thomas,
Nerreter, Thomas 1986-,
T Nerreter
Institution:
Universitätsklinikum Würzburg
Observed institutions:
Goethe University Frankfurt,
University of Würzburg,
Comprehensive Cancer Center Mainfranken,
Universitätsklinikum Würzburg,
University Hospital Frankfurt
ORCID:
0000-0002-0493-1369
Observed ORCID:
0000-0002-0493-1369
OpenAlex ID:
A5016385634
Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer
2021
·
Maik Luu
, Zeno Riester
, et al.
·
Nature Communications
·
865
PDF
The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells
2019
·
Katrin Mestermann
, Theodoros Giavridis
, et al.
·
Science Translational Medicine
·
561
CAR T-cells targeting FLT3 have potent activity against FLT3−ITD+ AML and act synergistically with the FLT3-inhibitor crenolanib
2018
·
Hardikkumar Jetani
, Irene Garcia-Cadenas
, et al.
·
Leukemia
·
215
ROR1-CAR T cells are effective against lung and breast cancer in advanced microphysiologic 3D tumor models
2019
·
Lars Wallstabe
, Claudia Göttlich
, et al.
·
JCI Insight
·
211
PDF
Super-resolution microscopy reveals ultra-low CD19 expression on myeloma cells that triggers elimination by CD19 CAR-T
2019
·
Thomas Nerreter
, Sebastian Letschert
, et al.
·
Nature Communications
·
181
PDF
CAR T cells targeting Aspergillus fumigatus are effective at treating invasive pulmonary aspergillosis in preclinical models
2022
·
Michelle Seif
, Tamara Katharina Kakoschke
, et al.
·
Science Translational Medicine
·
121
Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab
2020
·
Estefanía García-Guerrero
, Ralph Götz
, et al.
·
Leukemia
·
78
Chimeric Antigen Receptor Library Screening Using a Novel NF-κB/NFAT Reporter Cell Platform
2018
·
Julian Rydzek
, Thomas Nerreter
, et al.
·
Molecular Therapy
·
62
PDF
CAR-T cells and TRUCKs that recognize an EBNA-3C-derived epitope presented on HLA-B*35 control Epstein-Barr virus-associated lymphoproliferation
2020
·
Anna Christina Dragon
, Katharina Zimmermann
, et al.
·
Journal for ImmunoTherapy of Cancer
·
57
PDF
Mining Naïve Rabbit Antibody Repertoires by Phage Display for Monoclonal Antibodies of Therapeutic Utility
2017
·
Haiyong Peng
, Thomas Nerreter
, et al.
·
Journal of Molecular Biology
·
50
ROR1-targeting switchable CAR-T cells for cancer therapy
2022
·
Haiyong Peng
, Thomas Nerreter
, et al.
·
Oncogene
·
39
Decoding the molecular interplay of CD20 and therapeutic antibodies with fast volumetric nanoscopy
2025
·
Arindam Ghosh
, Mara Meub
, et al.
·
Science
·
36
PDF
Antibody‐Based CAR T Cells Produced by Lentiviral Transduction
2020
·
Sabrina Prommersberger
, Michael Hudecek
, et al.
·
Current Protocols in Immunology
·
36
PDF
Karanjin interferes with ABCB1, ABCC1, and ABCG2
2014
·
Martin Michaelis
, Florian Rothweiler
, et al.
·
Journal of Pharmacy & Pharmaceutical Sciences
·
35
Sorafenib paradoxically activates the RAS/RAF/ERK pathway in polyclonal human NK cells during expansion and thereby enhances effector functions in a dose- and time-dependent manner
2018
·
J Lohmeyer
, T Nerreter
, et al.
·
Clinical & Experimental Immunology
·
31
Novel targets and technologies for CAR-T cells in multiple myeloma and acute myeloid leukemia
2018
·
Sabrina Prommersberger
, Hardikkumar Jetani
, et al.
·
Current Research in Translational Medicine
·
23
Differential Effects of the Oncogenic BRAF Inhibitor PLX4032 (Vemurafenib) and its Progenitor PLX4720 on ABCB1 Function
2014
·
Martin Michaelis
, Florian Rothweiler
, et al.
·
Journal of Pharmacy & Pharmaceutical Sciences
·
19
Association between acquired resistance to PLX4032 (vemurafenib) and ATP-binding cassette transporter expression
2014
·
Martin Michaelis
, Florian Rothweiler
, et al.
·
BMC Research Notes
·
18
PDF
Mutation-specific CAR T cells as precision therapy for IGLV3-21R110 expressing high-risk chronic lymphocytic leukemia
2024
·
Florian Märkl
, Christoph Schultheiß
, et al.
·
Nature Communications
·
17
PDF
Characterization and Optimization of the Tumor Microenvironment in Patient-Derived Organotypic Slices and Organoid Models of Glioblastoma
2023
·
Vera Nickl
, Juliana Eck
, et al.
·
Cancers
·
15
PDF
Dasatinib enhances migration of monocyte-derived dendritic cells by reducing phosphorylation of inhibitory immune receptors Siglec-9 and Siglec-3
2014
·
Thomas Nerreter
, Christoph Köchel
, et al.
·
Experimental Hematology
·
12
PDF
Balancing the efficacy and safety of chimeric antigen receptor T-cell therapy by affinity combination
2026
·
Linda Warmuth
, Sarah Dötsch
, et al.
·
Nature Communications
·
8
PDF
Co-expression of an adapter CAR retains efficacy of CAR T cells after single and dual antigen loss in lymphoma
2025
·
Zeno Riester
, Marlena Surowka
, et al.
·
Molecular Therapy
·
8
ROR2-specific CAR T cells are effective against hematologic and solid tumors and well tolerated in mice
2025
·
Justus Weber
, Michael Rade
, et al.
·
Cell Reports Medicine
·
8
Combining dasatinib with dexamethasone long-term leads to maintenance of antiviral and antileukemia specific cytotoxic T cell responses in vitro
2013
·
Thomas Nerreter
, Eva Distler
, et al.
·
Experimental Hematology
·
8
Show more works
View as search
Works count:
64
Citation count:
2,763
H-index:
18
I10-index:
21
Year
Topic
Type